Eija Mahlamäki

2.2k citations

35 papers · 1.7k indexed · h-index 19

Hematology top 2%
- Hematopoietic Stem Cell Transplantation 5
- Multiple Myeloma Research and Treatments 3
- Blood Coagulation and Thrombosis Mechanisms 3
- Acute Myeloid Leukemia Research 3
Cancer Research top 5%
- Cancer Genomics and Diagnostics 9
Oncology top 5%
- Pancreatic and Hepatic Oncology Research 7
Molecular Biology top 10%
Genetics top 10%
- Genomic variations and chromosomal abnormalities 9
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 5

Co-authors: Anne Kallioniemi Esa Jantunen Ritva Karhu T. Nousiainen Olli Kallioniemi Ludmila Gorunova Mattias Höglund Taru Kuittinen
Cited by: Hematology Cancer Research Oncology
Journals: Genes Chromosomes and Cancer (6 papers)Bone Marrow Transplantation (5 papers)Annals of Hematology (2 papers)
Partner nations: Finland Sweden United States

In The Last Decade

Eija Mahlamäki

35 papers receiving 1.7k citations

Peers

Countries citing papers authored by Eija Mahlamäki

Since Specialization

Citations

This map shows the geographic impact of Eija Mahlamäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eija Mahlamäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eija Mahlamäki more than expected).

Fields of papers citing papers by Eija Mahlamäki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eija Mahlamäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eija Mahlamäki. The network helps show where Eija Mahlamäki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Eija Mahlamäki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eija Mahlamäki Line = papers co-authored together Eija Mahlamäki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cost analysis of a randomized stem cell mobilization study in multiple myeloma Annals of Hematology ·Ville Varmavuo,Raija Silvennoinen,Pekka Anttila,Marjaana Säily,Marja Sankelo,猪又潔,Jouni Ahonen,Eija Mahlamäki,Pentti Mäntymaa,Eeva‐Riitta Savolainen,Kari Remes,Esa Jantunen	2016	8
2	Kinetics of blood CD34+ cells after chemotherapy plus G-CSF in poor mobilizers: Implications for pre-emptive plerixafor use Annals of Hematology ·Esa Jantunen,Ville Varmavuo,Auni Juutilainen,Taru Kuittinen,Eija Mahlamäki,Pentti Mäntymaa,T. Nousiainen	2012	24
3	Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experience European Journal Of Haematology ·Esa Jantunen,Taru Kuittinen,Eija Mahlamäki,Marja Pyörälä,Pentti Mäntymaa,Tapio Nousiainen	2011	36
4	Is reduced ornithine-δ-aminotransferase activity the cause of vigabatrin-associated visual field defects? Epilepsy Research ·Iiris Sorri,Mitchell Brigell,M. Mályusz,Eija Mahlamäki,F. H. Bradford,Reetta Kälviäinen	2010	10
5	Is Smoking an Independent Risk Factor for Invasive Cervical Cancer? A Nested Case-Control Study Within Nordic Biobanks American Journal of Epidemiology ·Alyse Laliberte,Tapio Luostarinen,Egil Jellum,Joakim Dillner,Matti Hakama,Pentti Koskela,Per Lenner,Arthur Löve,Eija Mahlamäki,S. Thoresen,Laufey Tryggvadóttír,Göran Wadell,Linda Youngman,Matti Lehtinen	2008	79
6	Intraventricular haemorrhage in very‐low‐birthweight preterm infants: Association with low prothrombin activity at birth Acta Paediatrica ·M.R. Llamas,Pekka Riikonen,Riitta Kekomäki,Elina Vahtera,Eija Mahlamäki,Xu K,Kirsti Heinonen	2005	15
7	Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications Oncogene ·Markus Heidenblad,David Lindgren,Joris A. Veltman,Tord Jonson,Eija Mahlamäki,Ludmila Gorunova,Ad Geurts van Kessel,Eric Schoenmakers,Mattias Höglund	2005	82
8	High-Resolution Genomic and Expression Profiling Reveals 105 Putative Amplification Target Genes in Pancreatic Cancer Neoplasia ·Eija Mahlamäki,Päivikki Kauraniemi,Outi Monni,Maija Wolf,Sampsa Hautaniemi,Anne Kallioniemi	2004	92
9	Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma Bone Marrow Transplantation ·Taru Kuittinen,T. Nousiainen,Paavo Halonen,Eija Mahlamäki,Esa Jantunen	2004	97
10	Development of selected coagulation factors and anticoagulants in preterm infants by the age of six months Thrombosis and Haemostasis ·Pekka Riikonen,Elina Vahtera,Eija Mahlamäki,Kirsti Heinonen,Riitta Kekomäki,M.R. Llamas	2004	10
11	Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma Bone Marrow Transplantation ·Esa Jantunen,Matti Putkonen,T. Nousiainen,T‐T. Pelliniemi,Eija Mahlamäki,Nataša Vajić	2003	63
12	Frequent amplification of 8q24, 11q, 17q, and 20q‐specific genes in pancreatic cancer Genes Chromosomes and Cancer ·Eija Mahlamäki,Maarit Bärlund,Minna Tanner,Ludmila Gorunova,Mattias Höglund,Ritva Karhu,Anne Kallioniemi	2002	140
13	Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. PubMed ·Farahnaz Forozan,Eija Mahlamäki,Outi Monni,Ye Chen‐Izu,Peng Ji-gang,Yuan Jiang,Gerald Gooden,Stephen P. Ethier,Anne Kallioniemi,Olli Kallioniemi	2000	228
14	Comparative Genomic Hybridization Reveals Frequent Losses of Chromosomes 1p and 3q in Pheochromocytomas and Abdominal Paragangliomas, Suggesting a Common Genetic Etiology American Journal Of Pathology ·Rafael Ibáñez Hernández,Eija Mahlamäki,Brita Nord,Magnus Kjellman,Ritva Karhu,Anders Höög,Н. П. Гончаров,Bin Tean Teh,Martin Bäckdahl,Catharina Larsson	2000	88
15	Comparative Genomic Hybridization and Conventional Cytogenetic Analyses in Childhood Acute Myeloid Leukemia Leukemia & lymphoma ·Ole Grann Andersson,辰州浪平,克彦小原,Jukka Kanerva,Marcelo L. Larramendy,Eija Mahlamäki,Ulla M. Saarinen‐Pihkala,Sakari Knuutila	1999	15
16	Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue Microarrays JNCI Journal of the National Cancer Institute ·Lukas Bubendorf,Meelis Kolmer,Juha Kononen,Pasi A. Koivisto,Spyro Mousses,Ye Chen‐Izu,Eija Mahlamäki,Peter Schraml,Holger Moch,Niels Willi,Abdel Elkahloun,T G Pretlow,Thomas C. Gasser,Michael J. Mihatsch,Guido Sauter,Olli Kallioniemi	1999	281
17	Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer Genes Chromosomes and Cancer ·Eija Mahlamäki,Mattias Höglund,Ludmila Gorunova,Ritva Karhu,Sigmund Dawiskiba,Åke Andrén‐Sandberg,Olli Kallioniemi,Bertil Johansson	1997	106
18	Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic leukemia Cancer Genetics and Cytogenetics ·Kristiina Heinonen,Eija Mahlamäki,Esa Hämäläinen,Tapio Nousiainen,Ilkka Mononen	1994	14
19	Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms Genes Chromosomes and Cancer ·Sakari Knuutila,Lasse Teerenhovi,Marcelo L. Larramendy,Erkki Elonen,Kaarle Franssila,Stella J. Nylund,T. Timonen,Kristiina Heinonen,Eija Mahlamäki,Robert Winqvist,Tapani Ruutu	1994	38
20	Analysis of phenotype and genotype of individual cells in neoplasms Cancer Genetics and Cytogenetics ·Sakari Knuutila,Marcelo L. Larramendy,Tapani Ruutu,Anders Paetau,Kristiina Heinonen,Eija Mahlamäki	1993	12

About Eija Mahlamäki

Eija Mahlamäki is a scholar working on Hematology, Cancer Research and Oncology, having authored 35 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Genomic variations and chromosomal abnormalities (9 papers), Pancreatic and Hepatic Oncology Research (7 papers), Hematopoietic Stem Cell Transplantation (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Multiple Myeloma Research and Treatments (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (383 citations), Cancer Research (417 citations) and Oncology (641 citations). Eija Mahlamäki has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Anne Kallioniemi, Esa Jantunen, Ritva Karhu, T. Nousiainen, Olli Kallioniemi, Ludmila Gorunova, Mattias Höglund, Taru Kuittinen, Ye Chen‐Izu and Outi Monni. Their work appears in journals such as Genes Chromosomes and Cancer, Bone Marrow Transplantation, Annals of Hematology, Acta Paediatrica and Neoplasia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact